Studies from our and other laboratories have shown that activation of STAT3 in response to chemotherapy treatment as pre-requisite for cancer stemness and related therapy-resistance in ovarian cancer cells [25, 26, 55–59]. This evidence concerns the gene STAT3 and ovarian carcinoma.